Vacancy Access to Medicine Foundation - closing on 01 Jun 2019

Company Engagement Officer

The Access to Medicine Foundation is looking for a Company Engagement Officer to join the team that manages the relationship between the Foundation and pharmaceutical companies. This includes facilitating the dissemination of the Foundation’s research and concurrent evaluations with companies. The company engagement team is responsible for the daily interactions with pharmaceutical companies and for up-to-date knowledge of the companies, including on their access-to-medicine initiatives, commercial strategy, organisational structure and key influencers in the companies.


1 year (with possibility of renewal).


3,000 – 3,900 EUR per month gross.


Amsterdam, the Netherlands.

Closing date:

Applications will be considered on a rolling basis.

Starting date:

As soon as possible.

The Access to Medicine Foundation is an independent non-profit organisation based in Amsterdam. Our mission is to stimulate and guide pharmaceutical companies to do more for the 2 billion people worldwide who cannot access the medicine they need. The core pillar of our work is researching how pharmaceutical companies address the availability, affordability and accessibility of their products in low- and middle-income countries. To turn our research into real-world change, we engage with leading organisations, including companies, NGOs and governments.

About the Role

The Company Engagement Officer will report to the Company Engagement Manager, and will be responsible for managing the relationship between the Foundation and pharmaceutical companies, with a particular focus on those companies in the scope of our research. Main responsibilities may include, but are not limited to:

  • Executing the Foundation’s engagement with companies across the research programmes: from the development of the research methodology and the data collection process to the dissemination of findings;
  • Proactively reach out to new pharmaceutical companies that are relevant for our strategic goals;
  • When needed: speaking and representing the Foundation at industry events, seminars and conferences; translating research and insights for wider audiences;
  • The Foundation’s everyday communication with companies covered by our research;
  • Engaging with companies on opportunities for change making, e.g., during the Foundation’s workshops with companies or after publication of the Foundation’s research reports;
  • Assisting the Company Engagement Manager and the Executive Director in their interactions with management- and executive-level leadership at companies;
  • Working with the Foundation’s other teams – Communications, Strategy, Research – to optimise engagement with companies and to contribute to other teams’ strategies based on learnings.

Profile and essential skills

  • A relevant postgraduate degree in medical, pharmacy, sciences or economics focused on health-related fields;
  • Work experience in the pharmaceutical industry is a plus;
  • Basic knowledge of the pharmaceutical and vaccine business;
  • Experience in external communications;
  • Experienced in working on multidisciplinary projects;
  • Excellent command of English, both spoken and written;
  • Affinity with diplomacy and relationship building;
  • Familiarity with global health issues;
  • Ability to translate research and insights for wider audiences;
  • Work independently on team goals and objectives;
  • Willingness and availability to travel and work in different time zones.


The Access to Medicine Foundation offers benefits that include 25 days’ annual leave (pro rata), company pension scheme, holiday allowance and reimbursement of public transport to work (if living beyond 10 km from the office). 

More about Research at the Foundation

The Access to Medicine Foundation analyses and compares pharmaceutical companies’ policies and practices regarding access to medicine in low- and middle-income countries. We benchmark more than 40 companies against each other, and identify best practices and progress gaps. Our main research programmes in the next two years are the Access to Medicine Index and the Antimicrobial Resistance Benchmark.

The Access to Medicine Index is a biennial evaluation of 20 of the world’s largest research-based pharmaceutical companies. The Antimicrobial Research Benchmark is a recent tool that will track how large research-based pharmaceutical companies, generic medicine manufacturers and biopharmaceutical companies are responding to the global rise of antimicrobial resistance. The Foundation also published the first Access to Vaccines Index in 2017, and occasionally publishes thematic studies focused on priority access topics, such as the fragility of the antibiotics supply chain.

Get a sense of how our work is used in the media and across the global health community.

How to apply

Interested candidates should send a motivation letter, CV and two references to Mrs Mireille Deen at

The application will not be considered unless it is complete and all supporting documentation has been provided. There will be no compensation for relocation costs.

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.